These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34662565)

  • 41. OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae.
    Abdel-Mottaleb Y; Vandendriessche T; Clynen E; Landuyt B; Jalali A; Vatanpour H; Schoofs L; Tytgat J
    Toxicon; 2008 Jun; 51(8):1424-30. PubMed ID: 18471844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory effects of hesperetin on Kv1.5 potassium channels stably expressed in HEK 293 cells and ultra-rapid delayed rectifier K(+) current in human atrial myocytes.
    Wang H; Wang HF; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
    Eur J Pharmacol; 2016 Oct; 789():98-108. PubMed ID: 27397430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blockade of Kv1.3 potassium channels inhibits differentiation and granzyme B secretion of human CD8+ T effector memory lymphocytes.
    Hu L; Wang T; Gocke AR; Nath A; Zhang H; Margolick JB; Whartenby KA; Calabresi PA
    PLoS One; 2013; 8(1):e54267. PubMed ID: 23382885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and characterization of a novel structural class of Kv1.3 inhibitors.
    Hendrickx LA; Dobričić V; Toplak Ž; Peigneur S; Mašič LP; Tomašič T; Tytgat J
    Bioorg Chem; 2020 May; 98():103746. PubMed ID: 32199306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
    Hu L; Pennington M; Jiang Q; Whartenby KA; Calabresi PA
    J Immunol; 2007 Oct; 179(7):4563-70. PubMed ID: 17878353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of 8-prenylnaringenin on the activity of voltage-gated Kv1.3 potassium channels in human Jurkat T cells.
    Gąsiorowska J; Teisseyre A; Uryga A; Michalak K
    Cell Mol Biol Lett; 2012 Dec; 17(4):559-70. PubMed ID: 22933043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genistein inhibits the activity of kv1.3 potassium channels in human T lymphocytes.
    Teisseyre A; Michalak K
    J Membr Biol; 2005 May; 205(2):71-9. PubMed ID: 16283587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression and biophysical properties of Kv1 channels in supragranular neocortical pyramidal neurones.
    Guan D; Lee JC; Tkatch T; Surmeier DJ; Armstrong WE; Foehring RC
    J Physiol; 2006 Mar; 571(Pt 2):371-89. PubMed ID: 16373387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.
    Jeong I; Choi BH; Yoon SH; Hahn SJ
    Biochem Pharmacol; 2012 Feb; 83(4):497-505. PubMed ID: 22146582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of antiarrhythmic drug propafenone effects on the c-type Kv1.4 potassium channel by PHo and K+.
    Wang Z; Wang S; Li J; Jiang X; Wang N
    J Korean Med Sci; 2009 Feb; 24(1):84-91. PubMed ID: 19270818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages.
    Vicente R; Escalada A; Villalonga N; Texidó L; Roura-Ferrer M; Martín-Satué M; López-Iglesias C; Soler C; Solsona C; Tamkun MM; Felipe A
    J Biol Chem; 2006 Dec; 281(49):37675-85. PubMed ID: 17038323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
    Chang SC; Huq R; Chhabra S; Beeton C; Pennington MW; Smith BJ; Norton RS
    FEBS J; 2015 Jun; 282(12):2247-59. PubMed ID: 25864722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of Kv1.3 Channels in Human Jurkat T Cells by Xanthohumol and Isoxanthohumol.
    Gąsiorowska J; Teisseyre A; Uryga A; Michalak K
    J Membr Biol; 2015 Aug; 248(4):705-11. PubMed ID: 25688010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory effects of N-methyl-D-aspartate (NMDA) and α
    Hwang S; Yoon B; Jo SH
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):3149-3161. PubMed ID: 37166464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of ginsenoside Rg(3) on human Kv1.4 channel currents without the N-terminal rapid inactivation domain.
    Lee JH; Choi SH; Lee BH; Shin TJ; Pyo MK; Hwang SH; Kim BR; Lee SM; Bae DH; Rhim H; Nah SY
    Biol Pharm Bull; 2009 Apr; 32(4):614-8. PubMed ID: 19336893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potent suppression of Kv1.3 potassium channel and IL-2 secretion by diphenyl phosphine oxide-1 in human T cells.
    Zhao N; Dong Q; Du LL; Fu XX; Du YM; Liao YH
    PLoS One; 2013; 8(5):e64629. PubMed ID: 23717641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets.
    Orbán C; Bajnok A; Vásárhelyi B; Tulassay T; Toldi G
    Cytometry A; 2014 Jul; 85(7):636-41. PubMed ID: 24827427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3.
    Rodrigues AR; Arantes EC; Monje F; Stühmer W; Varanda WA
    Br J Pharmacol; 2003 Jul; 139(6):1180-6. PubMed ID: 12871837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The voltage- and time-dependent blocking effect of trifluoperazine on T lymphocyte Kv1.3 channels.
    Teisseyre A; Michalak K
    Biochem Pharmacol; 2003 Feb; 65(4):551-61. PubMed ID: 12566082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel effects of dendrotoxin homologues on subtypes of mammalian Kv1 potassium channels expressed in Xenopus oocytes.
    Robertson B; Owen D; Stow J; Butler C; Newland C
    FEBS Lett; 1996 Mar; 383(1-2):26-30. PubMed ID: 8612784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.